SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001005150-04-001263
Filing Date
2004-05-28
Accepted
2004-05-28 09:33:22
Documents
1
Period of Report
2004-06-23
Effectiveness Date
2004-05-28

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE 14A def14a.txt DEF 14A 110750
  Complete submission text file 0001005150-04-001263.txt   112414
Mailing Address 3 BETHESDA METRO CENTER SUITE 700 BETHESDA MD 20814
Business Address 3 BETHESDA METRO CENTER SUITE 700 BETHESDA MD 20814 3019611992
REGENERX BIOPHARMACEUTICALS INC (Filer) CIK: 0000707511 (see all company filings)

IRS No.: 521253406 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 000-15070 | Film No.: 04836772
SIC: 2834 Pharmaceutical Preparations